Weekly vaginal administration of tamoxifen for three months in postmenopausal women with vulvar and vaginal atrophy: a possible new treatment approach?

Journal Title: Clinical and Experimental Obstetrics & Gynecology - Year 2019, Vol 46, Issue 2

Abstract

An exploratory study was conducted recruiting four healthy postmenopausal women suffering from vulvar and vaginal atrophy (VVA). Subjects self-administered vaginal suppositories containing tamoxifen (20 mg). Subjects were instructed to insert one suppository vaginally once daily for one week and twice weekly over a period of three months. Vaginal pH and dryness scores using a visual analog scale (VAS) were recorded at enrollment and subsequent assessments were recorded using self-assessment questionnaires over a three- month period. Serum tamoxifen levels were measured after two months of suppository use. After three months, both vaginal pH and vaginal dryness symptoms showed significant improvement. Vaginal pH scores improved approximately 30% compared to baseline by completion of the study. Vaginal dryness scores improved approximately 63% compared to baseline. As expected, serum tamoxifen levels were negligible ranging from 1.0 ng/ml to 10.0 ng/ml determined after eight weeks on the treatment. The present results suggest that delivery of tamoxifen directly to the vaginal epithelium for the treatment of VVA may be a viable new treatment approach. Therefore, this route of administration may offer an important treatment modality for patients with a history of breast cancer, at risk for breast cancer, and who have hormone-receptor-positive breast cancer, including estrogen receptor-positive (ER-positive), and progesterone receptor- positive (PR-positive) in addition to node negative breast cancer.

Authors and Affiliations

J. Chollet, L. A. Meyn, F. Mermelstein

Keywords

Related Articles

Influence of route of delivery on perinatal outcomes in fetuses with myelomeningocele

The optimal route of delivery of fetuses with myelomeningocele is controversial. The aim of this study is to determine whether route of delivery predisposes to perinatal complications and influences short-term outcomes i...

Downregulation of Hsp27 inhibits proliferation, migration and invasion in human choriocarcinoma cell line JAR

Purpose of Investigation: Heat shock protein 27 (Hsp27), a member of the heat shock protein (Hsp) family, is critical in the stress response. However, the role of Hsp27 in the pathogenesis of preeclampsia remains unknown...

Selective medical treatment of heterotopic interstitial pregnancy

A new case of interstitial pregnancy after embryos transfer is reported. The interstitial pregnancy was one of twin pregnancy who was diagnosed sonographically and selectively interrupted at the 15 th week. The residual...

The course and outcome of pregnancy in patient with concomitant Gilbert syndrome and hereditary spherocytosis: a unique case report

Gilbert syndrome (GS) is an autosomal dominant mild unconjugated hyperbilirubinemia. Hereditary spherocytosis (HS) is an inherited condition of non-immune heterogeneous hemolytic anemia. These two diseases can be very ra...

A live normal baby is possible despite exposure of a cleaving embryo in culture to extensive smoke and heat from a raging fire and exposure to chemicals used to extinguishing the fire

Purpose: To demonstrate that some embryos can be exposed to fire and smoke and still be rescued and result in a healthy baby following embryo transfer. Materials and Methods: Valiant efforts were made to save cleaving em...

Download PDF file
  • EP ID EP620253
  • DOI 10.12891/ceog4948.2019
  • Views 63
  • Downloads 0

How To Cite

J. Chollet, L. A. Meyn, F. Mermelstein (2019). Weekly vaginal administration of tamoxifen for three months in postmenopausal women with vulvar and vaginal atrophy: a possible new treatment approach?. Clinical and Experimental Obstetrics & Gynecology, 46(2), 285-288. https://www.europub.co.uk/articles/-A-620253